Skip to main content
SpringerLink
Log in

Rationale and Feasibility of Intranasal Delivery of Drugs to the Eustachian Tube Orifice

  • OTITIS (DP SKONER, SECTION EDITOR)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Intranasal medication for eustachian tube dysfunction (ETD) is an established practice in otolaryngology through the effects of steroids, decongestants, antihistamines or a combination of the above in reducing tubal oedema. The author has previously argued that a double-blind, randomised control trial would be helpful in determining effectiveness of treatment, if a standardised head position, chiefly Mygind or Ragan, was adopted to maximise intranasal drop delivery into the eustachian tube orifice. One recent paper suggests that intranasal treatment is not very effective, but ultimately does not state whether a standardised head position was adopted. Although a large body of evidence supports the hypothesis that the nasal passages are the route to middle ear disease, there is as yet no paper that has been published that has specifically addressed this issue, therefore the author must conclude that evidence to support intranasal treatment for ETD is still lacking and further research is desirable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Fireman P. Otitis media and eustachian tube dysfunction: connection to allergic rhinitis. J Allergy Clin Immunol. 1997;99:S787–97.

    Article  PubMed  CAS  Google Scholar 

  2. Lildholdt T, Cantekin EI, Bluestone C, Rockette H. Effect of a topical nasal decongestant on Eustachian tube function in children with tympanotomy tubes. Acta Otolaryngol. 1982;94:93–7.

    Article  PubMed  CAS  Google Scholar 

  3. Tracy J, Dermain J, Hoffman K, Goetz D. Intranasal beclomethasone as an adjunct to the treatment of chronic middle ear effusion. Ann Allergy. 1998;80:198–206.

    Article  CAS  Google Scholar 

  4. Venkatayan N, Troublefield Y, Connelly P, Mautone A, Chandrasekhar S. Intranasal surfactant aerosol therapy for otitis media with effusion. Laryngoscope. 2000;110:1857–60.

    Article  PubMed  CAS  Google Scholar 

  5. Elies W. Topical steroids in the treatment of mucosal swelling of the nasal cavity. J Chemother. 1997;6:31–4.

    Google Scholar 

  6. Shapiro G, Bierman C, Furukawa C, Pierson W, Berman R, Donaldson J, et al. Treatment of persistent eustachian tube dysfunction in children with aerosolized nasal dexamethasone phosphate versus placebo. Ann Allergy. 1982;49:81–5.

    PubMed  CAS  Google Scholar 

  7. Danner C. Middle ear atelectasis: what causes it and how is it corrected? Otolaryngol Clin North Am. 2006;39:1211–19.

    Article  PubMed  Google Scholar 

  8. Friedman RA, Doyle W, Casselbrant M, Bluestone C, Fireman P. Immunological-mediated eustachian tube obstruction: a double-blind crossover study. J Allergy Clin Immunol. 1993;71:442–7.

    Article  Google Scholar 

  9. Skoner D, Doyle WJ, Fireman P. Eustachian tube obstruction (ETO) after histamine nasal provocation—a double blind dose response study. J Allergy Clin Immunol. 1987;79:27–31.

    Article  PubMed  CAS  Google Scholar 

  10. Skoner DP, Lee L, Doyle WJ, Chamowitz A, Fireman P. Eustachian tube obstruction (ETO) after intranasal challenge with house dust mite. Arch Otolaryngol. 1986;112:840–2.

    Article  CAS  Google Scholar 

  11. Bernstein J. Role of allergy in eustachian tube blockage and otitis with effusion: a review. Otolaryngol Head Neck Surg. 1996;114:562–7.

    Article  PubMed  CAS  Google Scholar 

  12. Mattucci K, Barak G. Middle ear effusion-allergy relationships. Ear Nose Throat J. 1995;74:752–8.

    PubMed  CAS  Google Scholar 

  13. Stenstrom C, Bylander-Groth A, Ingvarsson L. Eustachian tube function in otitis prone and healthy children. Int J Pediatr Otorhinolaryngol. 1991;21:127–38.

    Article  PubMed  CAS  Google Scholar 

  14. Kraemmer M, Marshaal S, Richardson M. Aetiological factors in the development of chronic middle ear effusions. Clinical Rev Allergy. 1984;2:319–28.

    Google Scholar 

  15. Yeo S, Park D, Eun Y, Cha C. The role of allergic rhinitis in the development of otitis media with effusion: effect on eustachian tube function. Am J Otolaryngol. 2007;28(3):148–52.

    Article  PubMed  Google Scholar 

  16. Martines F, Martinciglio G, Martines E, Bentivegna D. The role of atopy in otitis media with effusion among primary school children: audiological investigation. Eur Arch Otorhinolaryngol. 2010;267(11):1673–8. Epub 2010 Jun 9.

    Article  PubMed  CAS  Google Scholar 

  17. Gultekin E, Develioğlu ON, Yener M, Ozdemir I, Külekçi M. Prevalence and risk factors for persistent otitis media with effusion in primary school children in Istanbul, Turkey. Auris Nasus Larynx. 2010;37(2):145–9. Epub 2009 Jun 21.

    Article  PubMed  Google Scholar 

  18. •• Karagama Y, Rashid M, Lancaster J, Karkanevatos A, William R. Intranasal delivery of drugs to eustachian tube orifice. J Laryngol Otol. 2011;125(9):934–9. This prospective five period cross-over study was published in 2011 and is the first to address the issue of optimal head position. It is postulated that the efficacy of intranasal delivery can only be ascertained if maximal delivery is achieved.

    Article  PubMed  CAS  Google Scholar 

  19. Thomas C, Simpson S, Butler C, van der Voort J. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2006;3CD001935

  20. Cengel S, Akyol M. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. Int J Pediatr Otorhinolaryngol. 2006;70(4):639–45. Epub 2005 Sep 16.

    Article  PubMed  CAS  Google Scholar 

  21. •• Gluth M, McDonald D, Weaver A, Bauch C, Beatty C, Orvidas L. Management of eustachian tube dysfunction with nasal steroid spray: a prospective, randomized, placebo-controlled trial. Arch Otolaryngol Head Neck Surg. 2011;137(5):449–55. This randomized, placebo-controlled, double-blind prospective clinical trial was published in 2011 to determine the efficacy of intranasal steroids in treating the tympanometric signs and symptoms of eustachian tube dysfunction. No statistical difference was demonstrated between active and placebo arms.

    Article  PubMed  Google Scholar 

  22. Jackson L, Light J, Rosenberg S, Silverstein H, Thompson J. Direct application of dexamethasone for the treatment of chronic eustachian tube dysfunction. ENT J. 2003;82(1).

  23. Karlidağ T, Kaygusuz I, Gök U, Yalçin S, Keleş E, Oztürk L. The efficacy of combining antibiotic treatment with topical intranasal steroid administration in the treatment of chronic otitis media with effusion. Kulak Burun Bogaz Ihtis Derg. 2002;9(4):257–62.

    PubMed  Google Scholar 

  24. Moran D, Mutchie K, Higbee M, Paul D. The use of antihistamine-decongestant in conjunction with an anti-infective drug in the treatment of acute otitis media. J Pediatr. 1982;101(1):132–6.

    Article  PubMed  CAS  Google Scholar 

  25. Stillwagon P, Doyle W, Fireman P. Effect of an antihistamine/decongestant on nasal and eustachian tube function following intranasal pollen challenge. Ann Allergy. 1987;58(6):442–6.

    PubMed  CAS  Google Scholar 

  26. van Heerbeek N, Ingels K, Rijkers G, Zielhuis G. Therapeutic improvement of eustachian tube function: a review. Clin Otolaryngol Allied Sci. 2002;27(1):50–6.

    Article  PubMed  Google Scholar 

  27. Cantekin E, Mandel E, Bluestone C, Rockette H, Paradise J, Stool S, et al. Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion (“secretory” otitis media) in children: results of a double-blind, randomized trial. N Engl J Med. 1983;308(6):297–301.

    Article  PubMed  CAS  Google Scholar 

  28. Turner R, Darden P. Effect of topical adrenergic decongestants on middle ear pressure in infants with common colds. Pediatr Infect Dis J. 1996;15(7):621–4.

    Article  PubMed  CAS  Google Scholar 

  29. Oshima T, Kikuchi T, Kawase T, Kobayashi T. Nasal instillation of physiological saline for patulous eustachian tube. Acta Otolaryngol. 2010;130(5):550–3.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. South West Deanery, Royal Devon and Exeter Hospital, Barrack Rd, Exeter, EX2 5DW, UK

    Mamun Rashid

Authors
  1. Mamun Rashid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mamun Rashid.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rashid, M. Rationale and Feasibility of Intranasal Delivery of Drugs to the Eustachian Tube Orifice. Curr Allergy Asthma Rep 12, 541–546 (2012). https://doi.org/10.1007/s11882-012-0310-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-012-0310-3

Keywords

Search

Navigation